Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Hib vaccine shortage

Executive Summary

Wyeth expects to resume full supply of its Hib vaccine by the end of the year. Wyeth stopped manufacturing the product in the winter of 2002 because the supplier of its shipping vials went out of business. The company has found a new supplier and is building inventory. CDC indicated that Aventis and Merck have stepped up production to meet the supply gap; the Wyeth product represents 30% of the market...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS041416

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel